22nd Sep 2020 19:32
Yourgene Health PLC - molecular diagnostics firm - Says pipeline of opportunities is "strong" and expects to benefit from "near-term accretive revenues from our Covid-19 solutions". Says products like Clarigene SARS-Cov-2 test provide company with "stronger foundation".
Current stock price: 18.05 pence
Year-to-date change: up 36%
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
YGEN.L